DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Jubilant Ingrevia Limited — Financial Results Updates

NSE 1 hr ago·27 Oct 2026, 9:02 am

Jubilant Ingrevia

Jubilant Ingrevia Limited has released its latest financial results, providing an update on its performance for the recent quarter. The company has reported its earnings, which reflect its operational activities and financial standing during this period.

This update is important for investors as it offers a snapshot of the company's current health. It highlights how the company is managing its costs and generating revenue, which are key factors for assessing its future potential and stability in the market.

Investors should look for details on the company's order book and any commentary on future growth plans. These elements will help in understanding the company's trajectory and how it plans to navigate the current market conditions.